(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

What is it about?

Methadone, an evidence-based opioid agonist therapy, can not be prescribed for treatment of opioid use disorder and is only available through federally certified opioid treatment programs. A scoping review examined the literature on office-based methadone and pharmacy dispensing. Six clinical trials and seven observational studies suggest that office-based methadone is safe for stable methadone patients. Pharmacy dispensing of methadone is common in Canada and Europe but is not allowed in the U.S. Access to office-based methadone with pharmacy dispensing could enhance access to opioid agonist therapy especially in rural communities.

Read more on Kudos…
The following have contributed to this page:
Dennis McCarty
' ,"url"));